Bacterial biofilm in upper respiratory tract infections

Current Infectious Disease Reports

Volumn 9, Issue 3, 2007, Pages 186-192

  Morris, David P ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ENZYME; BACTERIAL VACCINE; FUSIDIC ACID; LIPOSOME; MACROLIDE; NE 1530; OFLOXACIN; OLIGOSACCHARIDE; PENICILLIN G; PHOTOSENSITIZING AGENT; POLYMER; RIFAMPICIN; UNCLASSIFIED DRUG; VANCOMYCIN; XYLITOL;

ACUTE SUPPURATIVE OTITIS MEDIA; ADENOID; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL GENETICS; BACTERIAL INFECTION; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BIOFILM; CHOLESTEATOMA; CHRONIC SINUSITIS; CLINICAL TRIAL; COMMENSAL; DISEASE COURSE; DRUG DELIVERY SYSTEM; EAR NOSE THROAT DISEASE; EVIDENCE BASED MEDICINE; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HOST PATHOGEN INTERACTION; HUMAN; METABOLITE; PENICILLIN RESISTANCE; PERSISTENT INFECTION; PLANKTON; REMISSION; REVIEW; RHINOSINUSITIS; SECRETORY OTITIS MEDIA; TONSILLITIS; UPPER RESPIRATORY TRACT INFECTION; VIRAL RESPIRATORY TRACT INFECTION;

EID: 34248366502     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-007-0030-3     Document Type: Review

References (56)

1. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
2. Costerton JW, Geesey GG, Cheng KJ: How bacteria stick. Sci Am 1978, 238:86-95.
3. Morris DP, Hagr A: Biofilm: Why the sudden interest? J Otolaryngol 2005, 34(Suppl 2):S56-59.
4. Anderl JN, Franklin MJ, Stewart PS: Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2000, 44:1818-1824.
5. Singh, PK, Schaefer AL, Parsek MR, et al.: Quorum sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000, 407:762-764.
6. Galli J, Ardito F, Cato L, et al.: Recurrent upper airway infections and bacterial biofilms. J Laryngol Otol 2006, Epub ahead of print.
7. Chun CK, Ozer EA, Welsh MJ, et al.: Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airway epithelia. Proc Natl Acad Sci U S A 2004, 101:3587-3590.
8. Singh PK, Parsek MR, Greenberg EP, Welsh MJ: A component of innate immunity prevents bacterial biofilm development. Nature 2002, 417:552-555.
9. Russell MW, Martin MH, Wu H-Y, et al.: Strategies of immunization against mucosal infection. Vaccine 2000, 19(Suppl 1):S122-S127.
10. Cundell D, Masure HR, Tuomanen EI: The molecular basis of pneumococcal infection: a hypothesis. Clin Infect Dis 1995, 21(Supp] 3):S204-S211.
11. Greiner LL, Watanabe H, Phillips NJ, et al.: Nontypeable Haemophilus influenzae strain 2019 produces a biofilm containing N-acetylneuraminic acid that may mimic sialylated O-linked glycans. Infect Immun 2004, 72:4249-4260.
12. Swords WE, Moore ML, Godzicki L, et al.: Sialylation of lipooligosaccharides promotes biofilm formation by nontypeable Haemophilus influenzae. Infect Immun 2004, 72:106-113.
13. Murphy TF, Kirkham C: Biofilm formation by nontypeable Haemophilus influenzae: strain variability, outer membrane antigen expression and role of pili. BMC Microbiol 2002, 2:7.
14. Vendeville A, Winzer K, Heurlier K, et al.: Making'sense' of metabolism: autoinducer-2, LuxS and pathogenic bacteria. Nat Rev Microbiol 2005, 3:383-396.
15. Petersen FC, Ahmed NA, Naemi A, Scheie AA: LuxS-mediated signalling in Streptococcus anginosus and its role in biofilm formation. Antonie Van Leeuwenhoek 2006, 90:109-121.
16. Osguthorpe JD: Adult rhinosinusitis: diagnosis and management. Am Fam Physician 2001, 63:69-76.
17. Perloff JR, Palmer JN: Evidence of bacterial biofilms on frontal recess stents in patients with chronic rhinosinusitis. Am J Rhinol 2004, 18:377-380.
18. Cryer J, Schipor 1, Perloff JR, Palmer JN: Evidence of bacterial biofilms in human chronic sinusitis. OR L J Otorhinolaryngol Relat Spec 2004, 66:155-158.
19. Ramadan HH, Sanclement JA, Thomas JG: Chronic rhinosinusitis and biofilms. Otolaryngol Head Neck Surg 2005, 132:414-417.
20. Ferguson BJ, Stolz DB: Demonstration of biofilm in human bacterial chronic rhinosinusitis. Am J Rhinol 2005, 19:452-457.
21. Sanclement JA, Webster P, Thomas J, Ramadan HH: Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope 2005, 115:578-58
22. Sanderson AR, Leid JG, Hunsaker D: Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Laryngoscope 2006, 116:1121-1126.
23. Bendouah Z, Barbeau J, Hamad WA, Desrosiers M: Use of an in vitro assay for determination of biofilm-forming capacity of bacteria in chronic rhinosinusitis. Am J Rhinol 2006, 20:434-438.
24. Bendouah Z, Barbeau J, Hamad WA, Desrosiers M: Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis. Otolaryngol Head Neck Surg 2006, 134:991-996.
25. Zuliani G, Carron M, Gurrola J, et al.: Identification of adenoid biofilms in chronic rhinosinusitis. Int J Pediatr Otorhinolaryngol 2006, 70:1613-1617.
26. Chole RA, Faddis BT: Anatomical evidence of microbial biofilms in tonsillar tissues: a possible mechanism to explain chronicity. Arch Otolaryngol Head Neck Surg 2003, 129:634-636.
27. Brook I, Yocum P: Comparison of the microbiology of group A and non-group A streptococcal tonsillitis. Ann Otol Rhinol Laryngol 1988, 97(3 Pt 1):243-246.
28. Stjernquist-Desatnik A, Holst E: Tonsillar microbial flora: comparison of recurrent tonsillitis and normal tonsils. Acta Otolaryngol 1999, 119:102-106.
29. Richardson MA: Sore throat, tonsillitis, and adenoiditis. Med Clin North Am 1999, 83:7S-83, viii.
30. Gaffney RJ, Cafferkey MT: Bacteriology of normal and diseased tonsils assessed by fine-needle aspiration: Haemophilus influenzae and the pathogenesis of recurrent acute tonsillitis. Clin Otolaryngol Allied Sci 1998, 23:181-185.
31. Kuhn JJ, Brook I, Waters CL, et al.: Quantitative bacteriology of tonsils removed from children with tonsillitis hypertrophy and recurrent tonsillitis with and without hypertrophy. Ann Otol Rhinol Laryngol 1995, 104:646-652.
32. Baldassarri L, Creti R, Recchia S, et al.: Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation. J Clin Microbiol 2006, 44:2721-2727.
33. Chole RA, Faddis BT: Evidence for microbial biofilms in cholesteatomas. Arch Otolaryngol Head Neck Surg 2002, 128:1129-1133.
34. Wang EW, Jung JY, Pashia ME, et al.: Otopathogenic Pseudomonas aeruginosa strains as competent biofilm formers. Arch Otolaryngol Head Neck Surg 2005, 131:983-989.
35. Males AG, Gray RF: Mastoid misery: quantifying the distress in a radical cavity. Clin Otolaryngol Allied Sci 1991, 16:12-14.
36. Bennett KE, Haggard MP, Silva PA, Stewart IA: Behaviour and developmental effects of otitis media with effusion into the teens. Arch Dis Child 2001, 85:91-95.
37. Tonnaer EL, Rijkers GT, Meis JF, et al.: Genetic relatedness between pneumococcal populations originating from the nasopharynx, adenoid, and tympanic cavity of children with otitis media. J Clin Microbiol 2005, 43:3140-3144.
38. Brook I: Anaerobic infections in children. Microbes Infect 2002, 4:1271-1280.
39. Rayner MG, Zhang Y, Gorry MC, et al.: Evidence of bacterial metabolic activity in culture-negative otitis media with effusion. JAMA 1998, 279:296-299.
40. Peizhong L, Whatmough K, Birchall JP, et al.: Does the bacterial DNA found in middle ear effusions come from viable bacteria? Clin Otolaryngol Allied Sci 2000, 25:570-576.
41. Hall-Stoodley L, Hu FZ, Gieseke A, et al.: Direct detection of bacterial biofilms on the middle-car mucosa of children with chronic otitis media. JAMA 2006, 296:202-211.
42. Post JC: Direct evidence of bacterial biofilms in otitis media. Laryngoscope 2001, 111:2083-2094.
43. Dohar JE, Hebda PA, Veeh R, et al.: Mucosal biofilm formation on middle ear mucosa in a nonhuman primate model of chronic suppurative otits media. Laryngoscope 2005, 115:1469-1472.
44. Mehta AJ, Lee JC, Stevens GR, Antonelli P: Opening plugged tympanostomy tubes: effect of biofilm formation. Otolaryngol Head Neck Surg 2006, 134:121-125.
45. Saginur R, Stdenis M, Ferris W, et al.: Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother 2006, 50:55-61.
46. Schultz MJ: Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis. J Antimicrob Chemother 2004, 54:21-28.
47. Smith AW: Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv Drug Deliv Rev 2005, 57:1539-1550.
48. Bayer AS, Park S, Ramos MC: Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosa. Infect Immun 1992, 60:3979-3985.
49. Wainwright M, Crossley KB: Photo sensitizing agents-circumventing resistance and breaking down biofilms: a review. Int Biodeterior Biodegrad 2004, 53:119-126.
50. Uhari M, Kontiokari T, Niemela M: A novel use of xylitol sugar in preventing acute otitis media. Pediatrics 1998, 102:879-884.
51. Uhari M, Tapiainen T, Kontiokari T: Xylitol in preventing acute otitis media. Vaccine 2000, 19(Suppl 1):S144-S147.
52. Ukkonen P, Varis K, Jernfors M, et al.: Treatment of acute otitis media with an antiadhesive oligosaccharide: a randomised, double-blind, placebo-controlled trial. Lancet 2000, 356:1398-1402.
53. Roos K, Grahn E, Lind L, Holm S: Treatment of recurrent streptococcal tonsillitis by recolonization with alpha-streptococci. Eur J Clin Microbiol Infect Dis 1989, 8:318-319.
54. Roos K, Hakansson EG, Holm S: Effect of recolonisation with "interfering" alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial. BMJ 2001, 322:210-212.
55. Tano K, Hakansson EG, Holm SE, Hellstrom S: Bacterial interference between pathogens in otitis media and alpha-haemolytic Streptococci analysed in an in vitro model. Acta Otolaryngol 2002, 122:78-85.
56. Bernstein JM, Haase E, Scannapieco F, et al.: Bacterial interference of penicillin-sensitive and -resistant Streptococcus pneumoniae by Streptococcus oralis in an adenoid organ culture: implications for the treatment of recurrent upper respiratory tract infections in children and adults. Ann Otol Rhinol Laryngol 2006, 115:350-356.